Corrigendum to “3D-QSAR-Based Pharmacophore Modeling, Virtual Screening, and Molecular Docking Studies for Identification of Tubulin Inhibitors with Potential Anticancer Activity”

Detalles Bibliográficos
Autores principales: Mirzaei, Salimeh, Ghodsi, Razieh, Hadizadeh, Farzin, Sahebkar, Amirhossein
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Corrigendum
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8758277/
https://www.ncbi.nlm.nih.gov/pubmed/35036443
http://dx.doi.org/10.1155/2022/9761279
_version_ 1784632863302352896
author Mirzaei, Salimeh
Ghodsi, Razieh
Hadizadeh, Farzin
Sahebkar, Amirhossein
author_facet Mirzaei, Salimeh
Ghodsi, Razieh
Hadizadeh, Farzin
Sahebkar, Amirhossein
author_sort Mirzaei, Salimeh
collection PubMed
description
format Online
Article
Text
id pubmed-8758277
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-87582772022-01-14 Corrigendum to “3D-QSAR-Based Pharmacophore Modeling, Virtual Screening, and Molecular Docking Studies for Identification of Tubulin Inhibitors with Potential Anticancer Activity” Mirzaei, Salimeh Ghodsi, Razieh Hadizadeh, Farzin Sahebkar, Amirhossein Biomed Res Int Corrigendum Hindawi 2022-01-06 /pmc/articles/PMC8758277/ /pubmed/35036443 http://dx.doi.org/10.1155/2022/9761279 Text en Copyright © 2022 Salimeh Mirzaei et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Corrigendum
Mirzaei, Salimeh
Ghodsi, Razieh
Hadizadeh, Farzin
Sahebkar, Amirhossein
Corrigendum to “3D-QSAR-Based Pharmacophore Modeling, Virtual Screening, and Molecular Docking Studies for Identification of Tubulin Inhibitors with Potential Anticancer Activity”
title Corrigendum to “3D-QSAR-Based Pharmacophore Modeling, Virtual Screening, and Molecular Docking Studies for Identification of Tubulin Inhibitors with Potential Anticancer Activity”
title_full Corrigendum to “3D-QSAR-Based Pharmacophore Modeling, Virtual Screening, and Molecular Docking Studies for Identification of Tubulin Inhibitors with Potential Anticancer Activity”
title_fullStr Corrigendum to “3D-QSAR-Based Pharmacophore Modeling, Virtual Screening, and Molecular Docking Studies for Identification of Tubulin Inhibitors with Potential Anticancer Activity”
title_full_unstemmed Corrigendum to “3D-QSAR-Based Pharmacophore Modeling, Virtual Screening, and Molecular Docking Studies for Identification of Tubulin Inhibitors with Potential Anticancer Activity”
title_short Corrigendum to “3D-QSAR-Based Pharmacophore Modeling, Virtual Screening, and Molecular Docking Studies for Identification of Tubulin Inhibitors with Potential Anticancer Activity”
title_sort corrigendum to “3d-qsar-based pharmacophore modeling, virtual screening, and molecular docking studies for identification of tubulin inhibitors with potential anticancer activity”
topic Corrigendum
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8758277/
https://www.ncbi.nlm.nih.gov/pubmed/35036443
http://dx.doi.org/10.1155/2022/9761279
work_keys_str_mv AT mirzaeisalimeh corrigendumto3dqsarbasedpharmacophoremodelingvirtualscreeningandmoleculardockingstudiesforidentificationoftubulininhibitorswithpotentialanticanceractivity
AT ghodsirazieh corrigendumto3dqsarbasedpharmacophoremodelingvirtualscreeningandmoleculardockingstudiesforidentificationoftubulininhibitorswithpotentialanticanceractivity
AT hadizadehfarzin corrigendumto3dqsarbasedpharmacophoremodelingvirtualscreeningandmoleculardockingstudiesforidentificationoftubulininhibitorswithpotentialanticanceractivity
AT sahebkaramirhossein corrigendumto3dqsarbasedpharmacophoremodelingvirtualscreeningandmoleculardockingstudiesforidentificationoftubulininhibitorswithpotentialanticanceractivity

Ejemplares similares